Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct:72:103215.
doi: 10.1016/j.scr.2023.103215. Epub 2023 Sep 27.

Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation

Bernardo Bonilauri  1 , Hye Sook Shin  1 , Min Htet  2 , Christopher D Yan  3 , Ronald M Witteles  1 , Karim Sallam  1 , Joseph C Wu  4
Affiliations

Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation

Bernardo Bonilauri et al. Stem Cell Res. 2023 Oct.

Abstract

Specific mutations in the TTR gene are responsible for the development of variant (hereditary) ATTR amyloidosis. Here, we generated two human induced pluripotent stem cell (iPSC) lines from patients diagnosed with Transthyretin Cardiac Amyloidosis (ATTR-CM) carrying heterozygous mutation in the TTR gene (i.e., p.Val30Met). The patient-derived iPSC lines showed expression of high levels of pluripotency markers, trilineage differentiation capacity, and normal karyotype. The generation of these iPSC lines represents a great tool for modeling patient-specific amyloidosis in vitro, allowing the investigation of the pathological mechanisms related to the disease in different cell types and tissues.

Keywords: Amyloid; Cardiac amyloidosis; Pluripotency; Stem cells; TTR; Transthyretin; iPSC.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Joseph C. Wu reports a relationship with Greenstone Biosciences that includes: co-founder & board member.

Figures

Fig. 1.
Fig. 1.
Characterization of cardiac amyloidosis patient-derived iPSC lines (SCVIi066-A and SCVIi067-A) with c.148G > A mutation in TTR gene.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Adams D, Koike H, Slama M, Coelho T, 2019. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nature Reviews. Neurology 15, 387–404. 10.1038/s41582-019-0210-4. - DOI - PubMed
    1. Giadone RM, Rosarda JD, Akepati PR, Thomas AC, Boldbaatar B, James MF, Wilson AA, Sanchorawala V, Connors LH, Berk JL, Wiseman RL, Murphy GJ, 2018. A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics. Amyloid 25, 148–155. 10.1080/13506129.2018.1489228. - DOI - PMC - PubMed
    1. Griffin JM, Rosenthal JL, Grodin JL, Maurer MS, Grogan M, Cheng RK, 2021. ATTR Amyloidosis: Current and emerging management strategies. JACC: Cardiooncology 3, 488–505. 10.1016/j.jaccao.2021.06.006. - DOI - PMC - PubMed
    1. Lau E, Paik DT, Wu JC, 2019. Systems-wide approaches in induced pluripotent stem cell models. Annual Review of Pathology: Mechanisms of Disease 14, 395–419. 10.1146/annurev-pathmechdis-012418-013046. - DOI - PMC - PubMed
    1. Ruberg FL, Berk JL, 2012. Transthyretin (TTR) Cardiac Amyloidosis. Circulation 126, 1286–1300. 10.1161/CIRCULATIONAHA.111.078915. - DOI - PMC - PubMed

MeSH terms